Immunome Inc
IMNMHealthcare|Biotechnology|USA
$23.35
-0.82 (-3.39%)
Tangible Book
$5.20
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (43)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Horn Kinney | CHIEF BUSINESS OFFICER | 2026-07-07 | SELL | 1,092 | $25 | $27.3K |
| Barchas Isaac | Director | 2026-07-07 | SELL | 100,000 | $24.13 | $2413K |
| Lechleider Robert | Chief Medical Officer | 2026-07-02 | SELL | 55,000 | $22.62 | $1244.1K |
| Barchas Isaac | Director | 2026-07-02 | SELL | 201,050 | $21.85 | $4392.9K |
| Lechleider Robert | Chief Medical Officer | 2026-06-25 | SELL | 55,000 | $19.85 | $1091.8K |
| Rosett Max | CFO | 2026-06-15 | SELL | 60,000 | $18.23 | $1093.8K |
| BIENAIME JEAN JACQUES | Director | 2026-06-05 | SELL | 10,500 | $19.41 | $203.8K |
| BIENAIME JEAN JACQUES | Director | 2026-06-05 | BUY | 10,500 | $19.45 | $204.2K |
| BIENAIME JEAN JACQUES | Director | 2026-05-15 | BUY | 5,000 | $20.7 | $103.5K |
| Higgins Jack | Chief Scientific Officer | 2026-04-02 | SELL | 9,438 | $21.64 | $204.2K |
| Rosett Max | CFO | 2026-04-02 | SELL | 65,000 | $21.92 | $1424.8K |
| SIEGALL CLAY B | President and CEO | 2026-03-27 | BUY | 25,450 | $19.67 | $500.6K |
| WAGENHEIM PHILIP | Director | 2026-03-23 | SELL | 65,000 | $20.55 | $1335.8K |
| BIENAIME JEAN JACQUES | Director | 2026-03-11 | BUY | 2,000 | $21.84 | $43.7K |
| SIEGALL CLAY B | President and CEO | 2025-12-30 | BUY | 4,729 | $21.15 | $100K |
| Barchas Isaac | Director | 2025-12-22 | SELL | 383,200 | $21.74 | $8330.8K |
| SIEGALL CLAY B | President and CEO | 2025-12-19 | BUY | 7,278 | $20.48 | $149.1K |
| Tsai Philip | Chief Technical Officer | 2025-12-19 | BUY | 10,000 | $20.49 | $204.9K |
| SIEGALL CLAY B | President and CEO | 2025-12-18 | BUY | 46,511 | $21.5 | $1000K |
| BIENAIME JEAN JACQUES | Director | 2025-06-03 | BUY | 5,000 | $9.38 | $46.9K |
| SIEGALL CLAY B | President and CEO | 2025-03-26 | BUY | 137,100 | $7.29 | $999.5K |
| BIENAIME JEAN JACQUES | Director | 2025-03-25 | BUY | 7,800 | $7.78 | $60.7K |
| BIENAIME JEAN JACQUES | Director | 2025-03-24 | BUY | 7,000 | $8.21 | $57.5K |
| Tsai Philip | Chief Technology Officer | 2025-03-24 | BUY | 12,300 | $8.42 | $103.6K |
| SIEGALL CLAY B | President and CEO | 2025-01-31 | BUY | 150,000 | $7.75 | $1162.5K |
| SIEGALL CLAY B | President and CEO | 2024-11-22 | BUY | 100,000 | $9.62 | $962K |
| Lechleider Robert | Chief Medical Officer | 2024-11-21 | BUY | 15,805 | $9.48 | $149.8K |
| Tsai Philip | Chief Technology Officer | 2024-11-21 | BUY | 21,000 | $9.43 | $198K |
| Rosett Max | CFO | 2024-09-19 | SELL | 14,380 | $16.01 | $230.2K |
| BIENAIME JEAN JACQUES | Director | 2024-08-16 | BUY | 7,000 | $13.94 | $97.6K |
| Higgins Jack | Chief Scientific Officer | 2024-08-15 | SELL | 3,524 | $13.93 | $49.1K |
| BIENAIME JEAN JACQUES | Director | 2024-05-21 | BUY | 2,000 | $13.57 | $27.1K |
| SIEGALL CLAY B | President and CEO | 2024-05-21 | BUY | 100,000 | $13.88 | $1388K |
| SIEGALL CLAY B | President and CEO | 2023-10-02 | BUY | 169,204 | $5.91 | $1000K |
| Turner Bruce | Chief Strategy Officer | 2023-10-02 | BUY | 42,300 | $5.91 | $250K |
| RAPP MICHAEL | Director | 2021-09-13 | BUY | 25,962 | $19.96 | $518.2K |
| RAPP MICHAEL | Director | 2021-09-10 | BUY | 45,950 | $18.07 | $830.3K |
| Lefenfeld Michael | Director | 2021-05-26 | BUY | 4,650 | $18.53 | $86.2K |
| RAPP MICHAEL | Director | 2021-05-26 | BUY | 53,498 | $18.38 | $983.3K |
| Sarma Purnanand D | President and CEO | 2021-05-25 | BUY | 10,500 | $18.41 | $193.3K |
| WAGENHEIM PHILIP | Director | 2021-05-24 | BUY | 13,500 | $18.35 | $247.7K |
| LAMATTINA JOHN L | Director | 2021-05-24 | BUY | 5,440 | $18.57 | $101K |
| RAPP MICHAEL | Director | 2020-10-06 | BUY | 83,332 | $12 | $1000K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked